Jiangsu Hengrui Medicine
600276.SS
#509
Rank
A$70.10 B
Marketcap
A$10.56
Share price
0.26%
Change (1 day)
-20.29%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2026 (TTM): A$0.22

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is A$0.22. In 2025 the company made an earnings per share (EPS) of A$0.26 an increase over its 2024 EPS that were of A$0.21.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$0.22-12.48%
2025A$0.2624.14%
2024A$0.2142.43%
2023A$0.148.77%
2022A$0.13-20.62%
2021A$0.17-26.59%
2020A$0.2327.24%
2019A$0.1828.41%
2018A$0.1420.04%
2017A$0.1231.21%
2016A$0.0884811.46%
2015A$0.0793836.27%
2014A$0.0582519.77%
2013A$0.0486418.05%
2012A$0.0412023.9%
2011A$0.0332526.9%
2010A$0.0262012.37%
2009A$0.0233256.6%
2008A$0.014899.18%
2007A$0.01364114.48%
2006A$0.00635964.83%
2005A$0.00385835.55%
2004A$0.00284629.73%
2003A$0.00219419.86%
2002A$0.001830-2.71%
2001A$0.0018821.02%
2000A$0.001862